The purpose of the guidelines is to assist nuclear medicine practitioners in recommending, performing, interpreting, and reporting the results of F-18-fluoro-2-deoxyglucose (18FDG)-PET imaging of the brain. Aim is to help in achieving a high quality standard of FDG imaging, which allows to increase the diagnostic impact of this technique in neurological and psychiatric practice.
